Friday June 14, 2019 Change 1.36% Price $2.24
Chart period: 2019-03-15 - 2019-06-14




Will APTO stock price go up or down on Mon, 17 Jun 2019?


Aptose Biosciences Forecast and Stock Analysis

Technical APTO stock analysis for Friday June 14, 2019.

Buy candidate since 2019-06-12 Gain 4.19%

Aptose Biosciences gained 1.36% in the last trading day ( Friday, 14th Jun 2019 ), rising from $2.21 to $2.24 , and has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During day the stock fluctuated 5.55% from a day low at $2.16 to a day high of $2.28. The price has risen in 6 of the last 10 days and is up by 12% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 210 954 more shares were traded than the day before. In total, 617 038 shares bought and sold for approximately $1.38 million.

Quick summary:

  • 30 day high of the APTO stock price was $2.28 and low was $1.81.
  • 90 day high was $2.45 and low was $1.81.
  • 52 week high for the Aptose Biosciences - $4.55 and low - $1.57.


Given the current horizontal trend you can expect Aptose Biosciences with 90% probability to be traded between $1.77 and $2.35 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Click here for today's Top 5 Trending Companies


Only positive signals in the chart today. Aptose Biosciences holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $2.03 and $2.05. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday June 07, 2019, which indicates further gains until a new top pivot has been found. Aptose Biosciences has rising volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 60 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $2.01 and $2.00.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Aptose Biosciences finds support just below today's level at $2.01. If this is broken, then the next support from accumulated volume will be at $2.00 and $1.85.

Support: $2.01 Price: $2.24 Resistance: $2.26


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.12 between high and low, or 5.55%. For the last week, the stock has had a daily average volatility of 8.74%.

Since the Aptose Biosciences has been rising for 6 days in a row, the risk for the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stoploss: $2.14 (-4.43%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 5 days ago.)

8.74 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Weaker Buy Today APTO ranks #293 as BUY CANDIDATE #293 Stronger Buy

Will APTO stock price go up or down on Mon, 17 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank